ITCMDBv1
Clinical TrialID 6866

Ephedrine Versus Ondansetron During Cesarean Delivery

NCT05127876

Spinal Induced Hypotension

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6866
Evidence Id
6866
Core Evidence Id
6866
Source Clinical Trial Id
6857
Herb2 Clinical Trial Id
HBCT006857
Nct Id
NCT05127876
Title
Ephedrine Versus Ondansetron During Cesarean Delivery
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Spinal Induced Hypotension
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
DRUG: Ondansetron 4 MG|DRUG: Ondansetron 8mg|DRUG: EPHEDrine 10 Mg/mL-NaCl 0.9% Intravenous Solution|OTHER: 10 mL normal saline
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Prevention
Gender
Female
Age
Adult
Enrollment
168
Outcome Measure
Incidence of Maternal hypotension, Mean arterial blood pressure was recorded every 2 minute for 10 minutes then every 5 minutes until delivery. Time of intrathecal injection was considered as 0 min., 45 minutes
Sponsor Collaborator
Ain Shams University
Funded By
OTHER
Location
Ain Shams University Hospitals, Cairo, Egypt
Other Id
R 04 2022
Start Date
2022-01-10
Primary Completion Date
2022-03-01
Completion Date
2022-03-06
First Posted
2021-11-19
Results First Posted
Last Update Posted
2022-09-09
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05127876
Title Cn
Title En
Ephedrine Versus Ondansetron During Cesarean Delivery
Bilingual Status
semi_complete